Free shipping on all orders over $ 500

GSK269962A

Cat. No. M5168

All AbMole products are for research use only, cannot be used for human consumption.

GSK269962A Structure
Synonym:

GSK 269962

Size Price Availability Quantity
10mM*1mL in DMSO USD 105  USD105 In stock
5mg USD 85  USD85 In stock
10mg USD 160  USD160 In stock
50mg USD 660  USD660 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

GSK269962A is a potent ROCK inhibitor with IC50 values of 1.6 and 4 nM for recombinant human ROCK1 and ROCK2, respectively. GSK269962A displays greater than 30-fold selectivity for ROCK against a panel of serine/threonine kinases. GSK269962A induces vasorelaxation in preconstricted rat aorta (IC50 = 35 nM). GSK269962A induced a reduction in blood pressure of approximately 10, 20, and 50 mm Hg at doses of 1, 3, and 30 mg/kg. GSK269962A represents a novel class of ROCK inhibitors that have profound effects in the vasculature and may enable us to further evaluate the potential beneficial effects of ROCK inhibition in animal models of cardiovascular as well as other chronic diseases.

Product Citations
Customer Product Validations & Biological Datas
Source Clin Cancer Res (2018). Figure 5. ROCK inhibitor (Abmole Bioscience)
Method
Cell Lines CP50 PDX-O
Concentrations 10 μM
Incubation Time 30 to 45 minutes
Results Nuclear BRD4 expression increased significantly (p=0.008) as patients progressed from HSPC
Chemical Information
Molecular Weight 570.6
Formula C29H30N8O5
CAS Number 850664-21-0
Solubility (25°C) DMSO 10 mM
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Hutchinson JL, et al. FASEB J. Lipopolysaccharide promotes contraction of uterine myocytes via activation of Rho/ROCK signaling pathways.

[2] Doe C, et al. J Pharmacol Exp Ther. Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities.

Related ROCK Products
OXA-06 hydrochloride 

OXA-06 hydrochloride is an ATP-competitive ROCK inhibitor that blocks anchorage-dependent growth and invasion of non-small cell lung cancer cell lines.

Y-33075 hydrochloride

Y-33075 hydrochloride (Y-39983) is a selective ROCK inhibitor derived from Y-27632, and is more potent than Y-27632, with an IC50 of 3.6 nM.

SR-3677 dihydrochloride 

SR-3677 dihydrochloride is a potent and selective ROCK-I and ROCK-II inhibitor with an IC50 values of 56 nM and 3 nM.

Akt/ROCK-IN-1

Akt/ROCK-IN-1 (B12) is a dual inhibitor for Akt and ROCK, with the IC50s of 0.023 nM and 1.47 nM, respectively.

Scaff10-8

Scaff10-8, bound to RhoA, inhibits the AKAP-Lbc-mediated RhoA activation.

  Catalog
Abmole Inhibitor Catalog




Keywords: GSK269962A, GSK 269962 supplier, ROCK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.